Issue 5

  • Dr. Anthony Fauci addresses ACR Convergence 2020, promotes public health measures to limit COVID-19

    Dr. Anthony Fauci addresses ACR Convergence 2020, promotes public health measures to limit COVID-19

    Before delivering his address during ACR Convergence 2020, Anthony S. Fauci, MD, was awarded the ACR Distinguished Global Public Health Award during the special session COVID-19: Public Health and Scientific Challenges.

  • Panel discusses emerging molecular insights from AMP SLE Network

    Panel discusses emerging molecular insights from AMP SLE Network

    With Phase 2 of the Accelerating Medicines Partnership (AMP) study of systemic lupus erythematosus (SLE) underway, an ACR Convergence 2020 session featured a panel that reviewed the methods being used to generate data and discussed some of the findings and insight gained from ongoing analyses…

  • Multidisciplinary approach needed to determine cardiac involvement in myositis and subsequent care

    Multidisciplinary approach needed to determine cardiac involvement in myositis and subsequent care

    Cardiovascular disease is the dominant cause of mortality in myositis patients, accounting for up to 55% of deaths.

  • Patient self-management of disease requires better buy-in from care providers

    Patient self-management of disease requires better buy-in from care providers

    Effective disease self-management for patients requires a patient-provider partnership, and an educational session at ACR Convergence 2020 offered practical steps for providers to encourage lupus patients to succeed at self-management.

  • New live Closing Session to feature crowdsourced highlights from ACR Convergence 2020

    New live Closing Session to feature crowdsourced highlights from ACR Convergence 2020

    NBC News medical contributor Natalie Azar, MD, will interview Annual Meeting Planning Committee Basic Science and Clinical Chairs Gregg Silverman, MD, and Diane Kamen, MD, MSCR.

  • Rheumatologists have role to play in ensuring patients get the most out of immunotherapy

    Rheumatologists have role to play in ensuring patients get the most out of immunotherapy

    As use of immune checkpoint inhibitors increases, so does the number of patients experiencing rheumatologic immune-related adverse events.

  • Checkpoint inhibitors’ adverse events mimic rheumatic diseases

    Checkpoint inhibitors’ adverse events mimic rheumatic diseases

    Checkpoint inhibitors have revolutionized the care of patients with certain cancers; however, patients treated with these therapies often develop immune-related adverse events that strongly resemble rheumatic autoimmune diseases.

  • Imaging interpretation critical in making correct axSpA diagnosis

    Imaging interpretation critical in making correct axSpA diagnosis

    Imaging plays a critical role in axial spondyloarthritis (axSpA) diagnosis, and three speakers will try to bring greater clarity to imaging issues during Controversies in the Diagnostic Evaluation of Axial Spondyloarthritis: An Experiential Review.